Rovsing (ROV) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
4 May, 2026Strategic positioning and market environment
Recognized as a European leader in spacecraft hardware and software testing equipment, supporting critical missions like Artemis and Galileo 2nd Generation.
Benefiting from record-high ESA and EU budgets, with Denmark tripling its ESA commitment and a 32% overall ESA budget increase for 2026–2028.
Strong pass-through of ESA budget growth to Danish industry, enhancing competitive positioning and contract opportunities.
Supports institutional, commercial, and military space programs, ensuring mission reliability and performance.
Tier 1 supplier to major aerospace primes and agencies, including Thales Alenia Space, NASA, Airbus, and Boeing.
Financial performance and turnaround
Completed a business turnaround, stabilizing financial performance and setting a foundation for growth.
H1 2025/26 revenue was DKK 13.4m, down 23% year-over-year, with EBITDA at DKK -3.6m due to project delays and higher costs.
One-off effects of DKK 2.5m in H1 2025/26 from project reviews and closure of Kourou activities; further impacts not expected.
Order backlog stable at DKK 33.1m as of December 2025, with a positive outlook for growth.
Maintains a book-to-bill ratio above 1, supporting revenue visibility and long-term growth.
Growth strategy and capital raise
Raising DKK 10.4m through a fully guaranteed rights issue to invest in growth, strengthen the balance sheet, and improve working capital.
Proceeds allocated: ~40% to growth investments, ~40% to working capital, ~20% to improving capital structure.
Capital raise aims to capitalize on record ESA and Danish budgets, increase operational flexibility, and reduce debt.
Strategic investments and organizational strengthening to enhance ability to win high-value and military contracts.
Focused marketing and sales initiatives to expand the order backlog and support profitable expansion.
Latest events from Rovsing
- Q3 saw lower revenue and EBITDA, but robust order intake underpins a positive annual outlook.ROV
Q3 24/2523 Apr 2026 - Revenue and EBITDA missed expectations, but backlog and tender activity remain strong.ROV
Q2 25/2620 Feb 2026 - Revenue and EBITDA missed Q1 targets, but order backlog and outlook remain strong.ROV
Q1 25/2611 Nov 2025 - Revenue fell 5.7% to DKK 37.0m, with a net loss of DKK 2.9m and stable order backlog.ROV
Q4 24/2516 Sep 2025 - Q1 revenue rose 17.3% year-over-year, with strong order intake and positive outlook.ROV
Q1 24/2513 Jun 2025 - H1 2024/25 saw lower earnings and revised guidance, but expansion plans remain on track.ROV
Q2 24/256 Jun 2025